BioAtla Inc.

NASDAQ: BCAB · Real-Time Price · USD
0.48
-0.03 (-5.46%)
At close: Jun 10, 2025, 3:59 PM

BioAtla Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
11M 11M 12.71M 1.71M 1.71M 1.71M n/a n/a n/a n/a 250K 400K 650K 650K 400K 400K 340K
Cost of Revenue
229K 469K 837K 1.11M 1.17M 1.22M 1.15M 1.18M 1.18M 1.2M 1.22M 1.29M 15.86M 15.85M 26.02M 30.51M 18.58M
Gross Profit
10.77M 10.53M 11.87M 599K 538K 485K -1.15M -1.18M -1.18M -1.2M -965K -895K -15.21M -15.2M -25.62M -30.11M -18.24M
Operating Income
-67.1M -73.94M -86.23M -109.98M -125.21M -129.69M -129.71M -120.87M -112.72M -108.14M -103.07M -100.58M -101.99M -96.44M -89.41M -73.73M -47.79M
Interest Income
2.55M 3.37M 4.45M 5.5M 6.05M 6.31M 5.72M 4.36M 3.04M 1.65M 697K 403K 337K 350K 317K 272K 193K
Pretax Income
-61.88M -69.78M -81.82M -104.56M -119.24M -123.46M -124.08M -116.53M -109.69M -106.48M -102.33M -99.48M -100.95M -95.4M -88.41M -77.11M -52.95M
Net Income
-61.88M -69.78M -81.82M -104.56M -119.24M -121.99M -122.83M -114.91M -107.92M -106.09M -101.72M -99.24M -100.86M -95.4M -88.41M -77.11M -52.95M
Selling & General & Admin
21.27M 21.38M 22.28M 23.02M 23.72M 25.59M 26.78M 26.5M 28.6M 28.79M 29.15M 29.95M 37.47M 38.42M 37.35M 33.51M 19.43M
Research & Development
56.6M 63.09M 74.12M 86.12M 100.89M 103.73M 102.93M 94.37M 84.12M 79.35M 73.92M 70.64M 64.77M 58.27M 52.31M 40.62M 28.7M
Other Expenses
229K 229K 202K 163K -77K -87K -90K -21K -7K 10K 42K 11K 8K 1K -1K n/a n/a
Operating Expenses
77.87M 84.47M 96.4M 109.15M 124.61M 129.32M 129.71M 120.87M 112.72M 108.14M 103.07M 100.58M 102.24M 96.69M 89.66M 74.13M 48.13M
Interest Expense
n/a n/a 1.47M 1.47M 1.47M 1.47M n/a 370K 516K 516K 516K 222K 77K 79K 81K 91K 844K
Selling & Marketing Expenses
-229K -469K -837K -837K -608K -368K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
78.1M 84.94M 97.23M 109.98M 125.21M 129.69M 129.71M 120.87M 112.72M 108.14M 103.07M 100.58M 102.24M 96.69M 89.66M 74.13M 48.13M
Income Tax Expense
n/a 196.72K 5.13M 3.13M 1.67M n/a -4.72M -3.08M -1.77M -390K -606K -237K -11K 179K 178K 265K 939K
Shares Outstanding (Basic)
58.25M 49.95M 48.34M 48.21M 48.09M 48.03M 47.83M 47.71M 47.58M 44.01M 37.52M 37.42M 37.32M 33.68M 33.91M 33.68M 33.63M
Shares Outstanding (Diluted)
58.25M 49.95M 48.34M 48.21M 48.09M 48.03M 47.83M 47.71M 47.58M 44.01M 37.52M 37.42M 37.32M 33.68M 33.91M 33.68M 33.63M
EPS (Basic)
-1.23 -1.45 -1.7 -2.18 -2.49 -2.56 -2.63 -2.61 -2.63 -2.73 -2.79 -2.79 -2.92 -2.83 -2.63 -2.33 -1.72
EPS (Diluted)
-1.23 -1.45 -1.7 -2.18 -2.49 -2.56 -2.63 -2.61 -2.63 -2.73 -2.79 -2.79 -2.92 -2.83 -2.63 -2.33 -1.72
EBITDA
-66.46M -73.25M -85.4M -109.11M -124.05M -128.47M -127.54M -118.67M -110.53M -105.92M -101.75M -98.43M -99.71M -94.07M -87.09M -75.81M -51.01M
EBIT
-65.74M -72.58M -86.23M -109.98M -125.21M -129.69M -128.69M -119.85M -111.71M -107.12M -102.97M -99.72M -101.05M -95.4M -88.4M -77.02M -52.11M
Depreciation & Amortization
868K 925K 1.06M 1.11M 1.17M 1.22M 1.15M 1.18M 1.18M 1.2M 1.22M 1.29M 1.33M 1.33M 1.31M 1.21M 1.1M